1. Home
  2. TXG vs BHE Comparison

TXG vs BHE Comparison

Compare TXG & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • BHE
  • Stock Information
  • Founded
  • TXG 2012
  • BHE 1979
  • Country
  • TXG United States
  • BHE United States
  • Employees
  • TXG N/A
  • BHE 11700
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • BHE Electrical Products
  • Sector
  • TXG Industrials
  • BHE Technology
  • Exchange
  • TXG Nasdaq
  • BHE Nasdaq
  • Market Cap
  • TXG 1.6B
  • BHE 1.4B
  • IPO Year
  • TXG 2019
  • BHE 1990
  • Fundamental
  • Price
  • TXG $11.76
  • BHE $37.35
  • Analyst Decision
  • TXG Buy
  • BHE Strong Buy
  • Analyst Count
  • TXG 12
  • BHE 2
  • Target Price
  • TXG $13.54
  • BHE $46.50
  • AVG Volume (30 Days)
  • TXG 2.7M
  • BHE 287.6K
  • Earning Date
  • TXG 10-28-2025
  • BHE 10-29-2025
  • Dividend Yield
  • TXG N/A
  • BHE 1.76%
  • EPS Growth
  • TXG N/A
  • BHE N/A
  • EPS
  • TXG N/A
  • BHE 1.05
  • Revenue
  • TXG $644,466,000.00
  • BHE $2,588,733,000.00
  • Revenue This Year
  • TXG $2.15
  • BHE $0.03
  • Revenue Next Year
  • TXG N/A
  • BHE $5.83
  • P/E Ratio
  • TXG N/A
  • BHE $36.88
  • Revenue Growth
  • TXG 2.02
  • BHE N/A
  • 52 Week Low
  • TXG $6.78
  • BHE $30.73
  • 52 Week High
  • TXG $20.92
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • TXG 41.80
  • BHE 38.88
  • Support Level
  • TXG $11.22
  • BHE $38.03
  • Resistance Level
  • TXG $13.22
  • BHE $39.37
  • Average True Range (ATR)
  • TXG 0.57
  • BHE 0.98
  • MACD
  • TXG 0.00
  • BHE -0.18
  • Stochastic Oscillator
  • TXG 27.18
  • BHE 4.31

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: